A recent study evaluating HER2 testing in a large cohort of women with breast cancer found important limitations in the conventional way HER2 testing is performed in the U.S. and internationally.
A Dartmouth researcher has found that reducing carbohydrate intake could reduce the risk of breast cancer recurrence among women whose tumor tissue is positive for the insulin-like growth factor 1 (IGF1) receptor.
In a recent study, offering support services soon after a patient’s diagnosis reduced depression among caregivers.
For nearly five decades, Geisel research Miguel Marin-Padilla has followed in the footsteps of Camillo Golgi by creating painstaking images that unravel the secrets of the brain.
In spite of early concerns that hospitals’ economic strengths would lead them to dominate the formation of Accountable Care Organizations (ACOs), a new study reveals the central role of physician leadership in the first wave of ACOs.
New research by an international group of scientists confirms a vulnerability to lung cancer can be inherited and implicates the BRCA2 gene as harboring one of the involved genetic mutations.
A $13 million, five-year grant will allow scientists at the Dartmouth Toxic Metals Superfund Research Program to continue and expand their research on the effects of exposure to arsenic, mercury, and other potential toxins on health.
A close look at the hormone leptin has revealed a link between methylation of the leptin gene and the development of male infants. The study was led by associate professor Carmen Marsit and graduate student Corina Lesseur.
Dr. Glyn Elwyn of the Dartmouth Center for Health Care Delivery Science is the principal investigator of a study on the use of two methods—shared decision-making and motivational interviewing—when discussing options for treatment with patients.
Using next generation DNA sequencing, Dartmouth scientists have identified potentially actionable mutations in cancers of the appendix. When specific mutations for a cancer type are identified, patients can be treated with chemotherapy or other targeted agents that work on those mutations.